Exogenous lysoPC altered transcriptomic profiles of lung cancer cells, of which ACSL5 was identified and validated as the target gene in lysoPC‐induced lung cancer cell hypoplasia and as a risk factor for lung cancer patient survival. The gene discussed is ACSL5; the disease is lung carcinoma.